Attributes Germane to Temporomandibular Disorders and Their Associations with Five Chronic Overlapping Pain Conditions

Aims: To investigate whether TMD-related characteristics are indeed specific to TMD or whether they are also associated with other chronic overlapping pain conditions (COPCs). Methods: In this cross-sectional study, 22 characteristics related broadly to TMD (eg, jaw kinesiophobia, overuse behaviors, and functional limitation) were measured in 178 painful TMD cases who were also classified according to four COPCs: headache, low back pain, irritable bowel syndrome, and fibromyalgia. Differences in mean subscale scores were compared according to individual chronic pain conditions and according to number of COPCs. Results: Headache, low back pain, irritable bowel syndrome, and fibromyalgia were each associated (P < .05) with higher values of at least one TMD-relevant characteristic. In the multivariable analysis, TMD was independently associated with 20 of the 22 characteristics (P < .01), and other COPCs were associated variably. A critical threshold existed between the number of COPCs and TMD characteristics: all characteristics were elevated for subjects with ≥ 3 COPCs (P ≤ .01). Conclusion: The overlap between COPCs and characteristics typically regarded as specific to painful TMD has implications for treatment targeted at both the local TMD condition and the broader pain disorder underlying the COPC(s). In TMD patients, the overall burden of pain from COPCs may create a shift in the pain-processing systems that underlie these TMD-relevant characteristics.

chronic overlapping pain conditions; comorbidity; pain;measurement; TMD

1. Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders—Pathways of vulnerability. Pain 2006;123:226–230.

2. Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: Implications for diagnosis and classification. J Pain 2016;17(9 suppl):T93–T107.

3. Yunus MB. Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339–356.

4. Functional pain disorders: Time for a paradigm shift. In: Mayer EA, Bushnell MC (eds). Functional Pain Syndromes: Presentation and Pathophysiology. Seattle: IASP, 2009:531–565.

5. Headache Classification Committee of the International Head ache Society (IHS). The International Classification of Headache Disorders, ed 3. Cephalalgia 2018;38:1–211.

6. NIH Working Group. Chronic Overlapping Pain Conditions: Summary of NIH Work Group Meeting to Develop Case Definition & Common Data Elements. https://www.iprcc.nih. gov/sites/default/files/Veasley-COPC.pdf. National Institutes of Health, 2015. Accessed May 6, 2020.

7. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344–349.

8. Bair E, Brownstein NC, Ohrbach R, et al. Study protocol, sample characteristics, and loss to follow-up: The OPPERA prospective cohort study. J Pain 2013;14(12 suppl):T2–T19.

9. Slade GD, Bair E, By K, et al. Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain 2011;12(11 suppl):T12–T26.

10. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

11. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology 2003;61:375–382.

12. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastro-enterology 2006;130:1480–1491.

13. Dionne CE, Dunn KM, Croft PR, et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) 2008;33:95–103.

14. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–172.

15. Visscher CM, Ohrbach R, van Wijk AJ, Wilkosz M, Naeije M. The Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD). Pain 2010;150:492–500.

16. Miller RP, Kori SH, Todd DD. The Tampa Scale: A measure of kinesiophobia. Clin J Pain 1991;7:51–52.

17. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 2000;85:317–332.

18. Visscher CM, Ohrbach R, van Wijk AJ, Wilkosz M, Naeije M. The Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD). Pain 2010;150:492–500.

19. Ohrbach R, Markiewicz MR, McCall WD Jr. Waking-state oral parafunctional behaviors: Specificity and validity as assessed by electromyography. Eur J Oral Sci 2008;116:438–444.

20. Markiewicz MR, Ohrbach R, McCall WD Jr. Oral behaviors checklist: Reliability of performance in targeted waking-state behaviors. J Orofac Pain 2006;20:306–316.

21. Ohrbach R. Assessment and further development of RDC/TMD Axis II biobehavioural instruments: A research programme progress report. J Oral Rehabil 2010;37:784–798.

22. Kaplan SE, Ohrbach R. Self-report of waking-state oral parafunctional behaviors in the natural environment. J Oral Facial Pain Headache 2016;30:107–119.

23. Ohrbach R. Disability assessment in temporomandibular disorders and masticatory system rehabilitation. J Oral Rehabil 2010;37:452–480.

24. Ohrbach R, Larsson P, List T. The Jaw Functional Limitation Scale: Development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain 2008;22:219–230.

25. Ohrbach R, Granger C, List T, Dworkin S. Preliminary development and validation of the Jaw Functional Limitation Scale. Community Dent Oral Epidemiol 2008;36:228–236.

26. Ohrbach R, Larsson P, List T. The Jaw Functional Limitation Scale: Development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain 2008;22:219–230.

27. Ohrbach R, Bair E, Fillingim RB, et al. Clinical orofacial charac-teristics associated with risk of first-onset TMD: The OPPERA prospective cohort study. J Pain 2013;1(12 suppl):T33–T50.

28. Ohrbach R, Gonzalez Y, List T, Michelotti A, Schiffman E. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Clinical Examination Protocol. http://www.rdc-tmdinter-national.org/. INfORM, 2014. Accessed May 7, 2020.

29. Dworkin SF, LeResche L, DeRouen T, Von Korff M. Assessing clinical signs of temporomandibular disorders: Reliability of clinical examiners. J Prosthet Dent 1990;63:574–579.

30. Ohrbach R, Bair E, Fillingim RB, et al. Clinical orofacial characteristics associated with risk of first-onset TMD: The OPPERA prospective cohort study. J Pain 2013;14(12 suppl):T33–T50.

31. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–172.

32. Richardson DB, Rzehak P, Klenk J, Weiland SK. Analyses of case-control data for additional outcomes. Epidemiology 2007;18:441–445.

33. Monsees GM, Tamimi RM, Kraft P. Genome-wide association scans for secondary traits using case-control samples. Genet Epidemiol 2009;33:717–728.

34. Bair E, Ohrbach R, Fillingim RB, et al. Multivariable modeling of phenotypic risk factors for first-onset TMD: The OPPERA pro-spective cohort study. J Pain 2013;14(12 suppl):T102–T115.

35. Tang F, Ishwaran H. Random forest missing data algorithms. Stat Anal Data Min 2017;10:363–377.

36. Fernández-Delgado M, Cernadas E, Barro S, Amorim D. Do we need hundreds of classifiers to solve real world classification problems? J Machine Learning Res 2014;15:3133–3181.

37. Lever J, Krzywinski M, Altman N. Points of significance: Classification evaluation. Nature Methods 2016;13:603–604.

38. Rufibach K. Use of Brier score to assess binary predictions. J Clin Epidemiol 2010;63:938–939.

39. Wallach H. Evaluation metrics for hard classifiers. Cambridge: Cavendish Laboratory, University of Cambridge, 2006.

40. Mohl ND. Reliability and validity of diagnostic modalities for temporomandibular disorders. Adv Dent Res 1993;7:113–119.

41. Sharma S, Crow HC, McCall WD Jr, Gonzalez YM. Systematic review of reliability and diagnostic validity of joint vibration analysis for diagnosis of temporomandibular disorders. J Orofac Pain 2013;27:51–60.

42. Ohrbach R, Fillingim RB, Mulkey F, et al. Clinical findings and pain symptoms as potential risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(11 suppl):T27–T45.

43. Glaros AG, Urban D, Locke J. Headache and temporomandibular disorders: Evidence for diagnostic and behavioural overlap. Cephalalgia 2007;27:542–549.

44. Svensson P. Muscle pain in the head: Overlap between tem-poromandibular disorders and tension-type headaches. Curr Opin Neurol 2007;20:320–325.

45. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemi-ologic comparison of pain complaints. Pain 1988;32:173–183.

46. Tchivileva IE, Ohrbach R, Fillingim RB, Greenspan JD, Maixner W, Slade GD. Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study. Pain 2017;158:120–129.

47. Plesh O, Wolfe F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: Prevalence and symptom severity. J Rheumatol 1996;23:1948–1952.

48. Greenwald JD, Shafritz KM. An integrative neuroscience framework for the treatment of chronic pain: From cellular alterations to behavior. Front Integr Neurosci 2018;12:18.

49. Raphael KG, Marbach JJ. Widespread pain and the effectiveness of oral splints in myofascial face pain. J Am Dent Assoc 2001;132:305–316.